Get started
Author

Adrián Sánchez‐Montalvá

Observed names: A Sanchez-Montalva, A Sánchez-Montalva, A Sánchez-Montalvá, A. SANCHEZ-MONTALVA, A. Sanchez-Montalva, A. Sánchez-Montalvá, Adrian Sanchez-Montalva, Adrian Sanchez-Montalvá, Adrian Sánchez-Montalva, Adrian Sánchez-Montalvá, Adrián Sánchez Montalvá, Adrián Sánchez-Montalva, Adrián Sánchez-Montalvà, Adrián Sánchez-Montalvá
Institutions: Hebron University, Universitat Autònoma de Barcelona, Instituto de Salud Carlos III, Vall d'Hebron Institut de Recerca, Centro de Investigación Biomédica en Red, Vall d'Hebron Hospital Universitari, Centro de Investigación Biomédica en Red Enfermedades Infecciosas, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Observed institutions: Hebron University, Universitat Autònoma de Barcelona, Uniformed Services University of the Health Sciences, Instituto de Salud Carlos III, Vall d'Hebron Institut de Recerca, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Vall d'Hebron Hospital Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, National Institute of Health Dr. Ricardo Jorge, Institut Català de la Salut, Centro de Investigación Biomédica en Red Enfermedades Infecciosas, Red de Investigación Cooperativa en Enfermedades Tropicales, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
ORCID: 0000-0002-2194-5447
Observed ORCID: 0000-0002-2194-5447
OpenAlex ID: A5059651140
Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
2014 · Israel Molina, Jordi Gómez i Prat, et al. · New England Journal of Medicine · 604
PDF
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
2020 · Juan Berenguer, Juan Berenguer, et al. · Clinical Microbiology and Infection · 401
PDF
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
2020 · Marina Tadolini, Luigi Ruffo Codecasa, et al. · European Respiratory Journal · 398
PDF
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers
2017 · Carlos A. Morillo, Hetty Waskin, et al. · Journal of the American College of Cardiology · 311
PDF
Experimental and Clinical Treatment of Chagas Disease: A Review
2017 · Policarpo Ademar Sales Junior, Israel Molina, et al. · American Journal of Tropical Medicine and Hygiene · 305
PDF
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts
2020 · I. Motta, R. Centis, et al. · Pulmonology · 241
PDF
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
2022 · Jérémy Manry, Paul Bastard, et al. · Proceedings of the National Academy of Sciences · 194
Toxic Profile of Benznidazole in Patients with Chronic Chagas Disease: Risk Factors and Comparison of the Product from Two Different Manufacturers
2015 · I. Molina, F. Salvador, et al. · Antimicrobial Agents and Chemotherapy · 107
PDF
Retinal microvascular abnormalities in patients after COVID-19 depending on disease severity
2020 · Miguel Ángel Zapata, Sandra Banderas García, et al. · British Journal of Ophthalmology · 102
PDF
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
2021 · Belén Gutiérrez-Gutiérrez, María Dolores del Toro, et al. · The Lancet Infectious Diseases · 95
PDF
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
2023 · Daniela Matuozzo, Estelle Talouarn, et al. · Genome Medicine · 80
PDF
Impact of the COVID-19 pandemic on tuberculosis management in Spain
2021 · M.L. Aznar, J. Espinosa-Pereiro, et al. · International Journal of Infectious Diseases · 75
PDF
Trypanosoma cruzi infection in a non-endemic country: epidemiological and clinical profile
2013 · F. Salvador, B. Trevióo, et al. · Clinical Microbiology and Infection · 75
Electrochemical POC device for fast malaria quantitative diagnosis in whole blood by using magnetic beads, Poly-HRP and microfluidic paper electrodes
2019 · Gisela Ruiz-Vega, Kevin Arias-Alpízar, et al. · Biosensors and Bioelectronics · 71
Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II superiority clinical trial
2020 · D. Molina-Morant, M. L. Fernández, et al. · Trials · 62
PDF
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
Usefulness of Strongyloides stercoralis Serology in the Management of Patients with Eosinophilia
2014 · Fernando Salvador, Elena Sulleiro, et al. · American Journal of Tropical Medicine and Hygiene · 59
The use of posaconazole against Chagas disease
2015 · Israel Molina, Fernando Salvador, et al. · Current Opinion in Infectious Diseases · 56
Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression
2019 · Pau Bosch-Nicolau, Maria Ubals, et al. · PLoS neglected tropical diseases · 55
PDF
MDR Tuberculosis Treatment
2022 · Juan Espinosa-Pereiro, Adrian Sánchez-Montalvá, et al. · Medicina · 54
PDF
Pharmacokinetics of Benznidazole in Healthy Volunteers and Implications in Future Clinical Trials
2017 · I. Molina, F. Salvador, et al. · Antimicrobial Agents and Chemotherapy · 50
Strongyloides stercoralis infection: A systematic review of endemic cases in Spain
2019 · Maria Barroso, Fernando Salvador, et al. · PLoS neglected tropical diseases · 49
PDF
Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial
2024 · Pau Bosch-Nicolau, Marisa L Fernández, et al. · The Lancet Infectious Diseases · 48
PDF
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL
2023 · Franz Koenig, Cécile Spiertz, et al. · EClinicalMedicine · 48
PDF
ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores
2021 · Milena S. Marcolino, Magda C. Pires, et al. · International Journal of Infectious Diseases · 48
PDF
Works count: 182
Citation count: 4,872
H-index: 34
I10-index: 85
Year
Topic
Type